These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 27631233)

  • 1. HLA-DR, and not PLA2R, is expressed on the podocytes in kidney allografts in de novo membranous nephropathy.
    Wen J; Xie K; Zhang M; Chen J; Zhang J; Cheng D; Li X; Ji S; Liu Z
    Medicine (Baltimore); 2016 Sep; 95(37):e4809. PubMed ID: 27631233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress on the M-type phospholipase A2 receptor in idiopathic membranous nephropathy.
    Wang C; Lu H; Yang C; Luo Y
    Chin Med J (Engl); 2014; 127(10):1960-3. PubMed ID: 24824263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membranous nephropathy: recent travels and new roads ahead.
    Beck LH; Salant DJ
    Kidney Int; 2010 May; 77(9):765-70. PubMed ID: 20182413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunology of membranous nephropathy: from animal models to humans.
    Sinico RA; Mezzina N; Trezzi B; Ghiggeri GM; Radice A
    Clin Exp Immunol; 2016 Feb; 183(2):157-65. PubMed ID: 26459770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of serum mannose-binding lectin, anti-phospholipase A2 receptor antibody and renal outcomes in idiopathic membranous nephropathy and atypical membranous nephropathy: a single center retrospective cohort study.
    Zhao Y; Cai M; Jiang Z; Dong B; Yan Y; Wang Y; Zuo L
    Ren Fail; 2022 Dec; 44(1):428-433. PubMed ID: 35272568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of phospholipase A2 receptor and IgG4 in patients with membranous nephropathy.
    Liu L; Chang B; Wu X; Guo Y; Pan Y; Yang L
    Vasc Health Risk Manag; 2018; 14():103-108. PubMed ID: 29881283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases.
    Radice A; Pieruzzi F; Trezzi B; Ghiggeri G; Napodano P; D'Amico M; Stellato T; Brugnano R; Ravera F; Rolla D; Pesce G; Giovenzana ME; Londrino F; Cantaluppi V; Pregnolato F; Volpi A; Rombolà G; Moroni G; Ortisi G; Sinico RA
    J Nephrol; 2018 Apr; 31(2):271-278. PubMed ID: 29081027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Routine immunohistochemical staining in membranous nephropathy: in situ detection of phospholipase A2 receptor and thrombospondin type 1 containing 7A domain.
    L'Imperio V; Pieruzzi F; Sinico RA; Nebuloni M; Granata A; Smith A; Radice A; Pagni F
    J Nephrol; 2018 Aug; 31(4):543-550. PubMed ID: 29626294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal Phospholipase A2 Receptor and the Clinical Features of Idiopathic Membranous Nephropathy.
    Xu NX; Xie QH; Sun ZX; Wang J; Li Y; Wang L; Liu SJ; Xue J; Hao CM
    Chin Med J (Engl); 2017 Apr; 130(8):892-898. PubMed ID: 28397717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. sPLA2-IB and PLA2R mediate insufficient autophagy and contribute to podocyte injury in idiopathic membranous nephropathy by activation of the p38MAPK/mTOR/ULK1
    Yang L; Wu Y; Lin S; Dai B; Chen H; Tao X; Li G; Wan J; Pan Y
    FASEB J; 2021 Feb; 35(2):e21170. PubMed ID: 33184968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. M-type phospholipase A
    Kanda S; Horita S; Yanagihara T; Shimizu A; Hattori M
    Pediatr Nephrol; 2017 Apr; 32(4):713-717. PubMed ID: 27921164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical value of renal phospholipase A2 receptor deposit in the prognosis evaluation and treatment options of idiopathic membranous nephropathy: A retrospective cohort study.
    Xie Z; Dong W; Li Z; Chen Y; Song L; Li R; Wu Y; Fu L; Liang H; Tao Y; Xie J; Wang W; Liu S; Ye Z; Shi W; Liang X
    Nephrology (Carlton); 2020 Mar; 25(3):219-229. PubMed ID: 31900967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between m-type phospholipase A2 receptor,human leukocyte antigen gene polymorphisms and idiopathic membranous nephropathy.
    Liu X; Xu W; Yu C; Wang M; Liu R; Xie R
    Bioengineered; 2021 Dec; 12(1):8833-8844. PubMed ID: 34607530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum with phospholipase A2 receptor autoantibodies interferes with podocyte adhesion to collagen.
    Škoberne A; Behnert A; Teng B; Fritzler MJ; Schiffer L; Pajek J; Lindič J; Haller H; Schiffer M
    Eur J Clin Invest; 2014 Aug; 44(8):753-65. PubMed ID: 24942189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between PLA2R1 and HLA-DQA1 variants associates with anti-PLA2R antibodies and membranous nephropathy.
    Lv J; Hou W; Zhou X; Liu G; Zhou F; Zhao N; Hou P; Zhao M; Zhang H
    J Am Soc Nephrol; 2013 Jul; 24(8):1323-9. PubMed ID: 23813219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-130a-5p prevents angiotensin II-induced podocyte apoptosis by modulating M-type phospholipase A2 receptor.
    Liu D; Liu F; Wang X; Qiao Y; Pan S; Yang Y; Hu Y; Zhang Y; Tian F; Liu Z
    Cell Cycle; 2018; 17(21-22):2484-2495. PubMed ID: 30394845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Phospholipase A2 Receptor (PLA2R) Antibody and Glomerular PLA2R Expression in Japanese Patients with Membranous Nephropathy.
    Hihara K; Iyoda M; Tachibana S; Iseri K; Saito T; Yamamoto Y; Suzuki T; Wada Y; Matsumoto K; Shibata T
    PLoS One; 2016; 11(6):e0158154. PubMed ID: 27355365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PLA2R and membranous nephropathy: A 3 year prospective Australian study.
    Hill PA; McRae JL; Dwyer KM
    Nephrology (Carlton); 2016 May; 21(5):397-403. PubMed ID: 26369693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship of anti-phospholipase A2 receptor antibody and C5a complement with disease activity and short-term outcome in idiopathic membranous nephropathy.
    Chi JN; Lai TS; Wu CF; Fu TY; Chou YH; Chiu YL; Lin WC; Chiang WC; Chen YM; Wu MS
    J Formos Med Assoc; 2019 May; 118(5):898-906. PubMed ID: 30639075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of urinary podocytes by flow cytometry in idiopathic membranous nephropathy.
    Mella A; Deambrosis I; Mingozzi S; Colla L; Burdese M; Giaretta F; Bruno S; Camussi G; Boaglio E; Dolla C; Clari R; Biancone L
    Sci Rep; 2020 Oct; 10(1):16362. PubMed ID: 33004982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.